Antiviral therapy for COVID-19: Derivation of optimal strategy based on past antiviral and favipiravir experiences
Kimiyasu Shiraki, Noriaki Sato, Kaoru Sakai, Shirou Matsumoto, Richard H. Kaszynski, Masaya Takemoto
Topics & Concepts
FavipiravirPneumoniaVirologyVirusMedicineImmunologyCoronavirusAntiviral drugFoscarnetHuman cytomegalovirusInternal medicineDiseaseInfectious disease (medical specialty)Coronavirus disease 2019 (COVID-19)GanciclovirCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchCytomegalovirus and herpesvirus research